Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Haematologica
|
August 21, 2020
A three-gene signature based on <i>MYC</i>, <i>BCL-2</i> and <i>NFKBIA</i> improves risk stratification in diffuse large B-cell lymphoma
Enrico Derenzini, Saveria Mazzara, Federica Melle, et al.
Cancer Immunology Research
|
April 1, 2022
Hallmarks of Resistance to Immune-Checkpoint Inhibitors
Maria Karasarides, Alexandria P Cogdill, Paul B Robbins, et al.
The Oncologist
|
December 30, 2025
EXTRA-PC: A phase II trial of masofaniten (EPI-7386) and enzalutamide for patients with treatment-naïve metastatic hormone-sensitive prostate cancer
Albert Jang, Peggy Fowler, Kathryn Helminiak, et al.
Science Translational Medicine
|
June 5, 2020
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia
Jayakumar Vadakekolathu, Mark D Minden, Tressa Hood, et al.
Journal of Translational Medicine
|
November 17, 2016
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015
Paolo A Ascierto, Sanjiv Agarwala, Gerardo Botti, et al.
Journal of Translational Medicine
|
June 5, 2013
Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012"
Paolo A Ascierto, Antonio M Grimaldi, Nicolas Acquavella, et al.
Plos One
|
January 14, 2021
Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity
Jason Ptacek, Rachael E Hawtin, Dongmei Sun, et al.
Cancers
|
September 10, 2021
Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx<sup>®</sup> Digital Spatial Profiler
Helga Bergholtz, Jodi M Carter, Alessandra Cesano, et al.
Journal for Immunotherapy of Cancer
|
April 18, 2020
Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
Paolo Antonio Ascierto, Bernard A Fox, Walter J Urba, et al.
Journal for Immunotherapy of Cancer
|
March 27, 2020
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Lorenzo Galluzzi, Ilio Vitale, Sarah Warren, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Haematologica
|
August 21, 2020
A three-gene signature based on <i>MYC</i>, <i>BCL-2</i> and <i>NFKBIA</i> improves risk stratification in diffuse large B-cell lymphoma
Enrico Derenzini, Saveria Mazzara, Federica Melle, et al.
Cancer Immunology Research
|
April 1, 2022
Hallmarks of Resistance to Immune-Checkpoint Inhibitors
Maria Karasarides, Alexandria P Cogdill, Paul B Robbins, et al.
The Oncologist
|
December 30, 2025
EXTRA-PC: A phase II trial of masofaniten (EPI-7386) and enzalutamide for patients with treatment-naïve metastatic hormone-sensitive prostate cancer
Albert Jang, Peggy Fowler, Kathryn Helminiak, et al.
Science Translational Medicine
|
June 5, 2020
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia
Jayakumar Vadakekolathu, Mark D Minden, Tressa Hood, et al.
Journal of Translational Medicine
|
November 17, 2016
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015
Paolo A Ascierto, Sanjiv Agarwala, Gerardo Botti, et al.
Journal of Translational Medicine
|
June 5, 2013
Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012"
Paolo A Ascierto, Antonio M Grimaldi, Nicolas Acquavella, et al.
Plos One
|
January 14, 2021
Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity
Jason Ptacek, Rachael E Hawtin, Dongmei Sun, et al.
Cancers
|
September 10, 2021
Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx<sup>®</sup> Digital Spatial Profiler
Helga Bergholtz, Jodi M Carter, Alessandra Cesano, et al.
Journal for Immunotherapy of Cancer
|
April 18, 2020
Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
Paolo Antonio Ascierto, Bernard A Fox, Walter J Urba, et al.
Journal for Immunotherapy of Cancer
|
March 27, 2020
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Lorenzo Galluzzi, Ilio Vitale, Sarah Warren, et al.
Page
of 9